Trevi Therapeutics Balance Sheet Health
Financial Health criteria checks 6/6
Trevi Therapeutics has a total shareholder equity of $82.5M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $89.4M and $6.9M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
Interest coverage ratio | n/a |
Cash | US$82.97m |
Equity | US$82.55m |
Total liabilities | US$6.86m |
Total assets | US$89.40m |
Recent financial health updates
Trevi Therapeutics (NASDAQ:TRVI) Is In A Good Position To Deliver On Growth Plans
Jan 27Is Trevi Therapeutics (NASDAQ:TRVI) Using Too Much Debt?
Mar 23Recent updates
Financial Position Analysis
Short Term Liabilities: TRVI's short term assets ($87.5M) exceed its short term liabilities ($5.8M).
Long Term Liabilities: TRVI's short term assets ($87.5M) exceed its long term liabilities ($1.0M).
Debt to Equity History and Analysis
Debt Level: TRVI is debt free.
Reducing Debt: TRVI has no debt compared to 5 years ago when its debt to equity ratio was 17.5%.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: TRVI has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: TRVI has sufficient cash runway for 1.6 years if free cash flow continues to reduce at historical rates of 12.3% each year.